"Northwest Clinical Trials is a locally-owned medical research clinic serving the greater Treasure Valley. Research participants are compensated for their time and receive study-related medical care at no cost. We currently have studies for migraines, Alzheimer's, obsessive-compulsive disorder (OCD), irritable bowel syndrome (IBS), and weight loss."

During the past decade, Northwest Clinical Trials conducted 29 clinical trials. In the 10-year time frame, 29 clinical trials started and 26 clinical trials were completed, i.e. on average, 89.7% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 19 clinical trials were completed. i.e. 211.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Northwest Clinical Trials" #1 sponsor was "Eli Lilly and Company" with 9 trials, followed by "Pfizer" with 7 trials sponsored, "Biohaven Pharmaceuticals, Inc." with 3 trials sponsored, "Actavis Inc." with 2 trials sponsored and "Allergan" with 2 trials sponsored. Other sponsors include 24 different institutions and companies that sponsored additional 31 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Northwest Clinical Trials" #1 collaborator was "CoLucid Pharmaceuticals" with 2 trials as a collaborator, "Syneos Health" with 2 trials as a collaborator, "Amsterdam UMC, location VUmc" with 1 trials as a collaborator, "Bristol-Myers Squibb" with 1 trials as a collaborator and "GlaxoSmithKline" with 1 trials as a collaborator. Other collaborators include 1 different institutions and companies that were collaborators in the rest 11 trials.

According to Clinical.Site data, the most researched conditions in "Northwest Clinical Trials" are "Onychomycosis" (6 trials), "Alzheimer Disease" (4 trials), "Acne Vulgaris" (3 trials), "Actinic Keratosis" (3 trials) and "Migraine" (3 trials). Many other conditions were trialed in "Northwest Clinical Trials" in a lesser frequency.

Most popular intervention types in "Northwest Clinical Trials" are "Drug" (52 trials), "Other" (4 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (19 trials), "Galcanezumab" (3 trials), "placebo" (3 trials), "Atogepant" (2 trials) and "Bococizumab (PF-04950615; RN316)" (2 trials). Other intervention names were less common.

The vast majority of trials in "Northwest Clinical Trials" are 49 trials for "All" genders and 3 trials for "Male" genders.

Currently, there are NaN active trials in "Northwest Clinical Trials". undefined are not yet recruiting, 5 are recruiting, 1 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 44 completed trials in Northwest Clinical Trials, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Northwest Clinical Trials, 0 "Phase 1" clinical trials were conducted, 21 "Phase 2" clinical trials and 33 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".